The sources behind the guides.
Read the same primary resources we use for product facts and health context.
All sources below were checked October 7, 2026. Inclusion is not an endorsement of this publication by the named organization. Product pages are provider claims; clinical resources about individual medicines do not establish the safety or effectiveness of a compounded combination.
- Panchaprateep and Lueangarun (2020): oral minoxidil in 30 men
Primary open-label single-arm study, 24 weeks; indexed abstract reviewed, not a trial of a tadalafil combination
- Ro: ED product catalog and plan quantities
Provider catalog; individual products, strengths and plan prices
- Hims: current ED treatment catalog
Provider catalog; individual named offers and starting prices
- Hims: generic tadalafil tablets
Provider product page; daily and as-needed tablet options
- Hims: branded Viagra
Provider product page; brand-name sildenafil and advertised price
- Hims: branded Cialis
Provider product page; branded tadalafil, distinct from generics
- Hims: Hard Mints formulation safety library
Provider formulation document; includes options not confirmed in the main catalog
- Hims: 3-in-1 Pill formulation and safety
Provider formulation document; sildenafil, tadalafil and vitamin B12
- Hims: Tadalafil Chews safety information
Provider formulation document; single-ingredient compounded tadalafil
- Hims: Sex Rx + Hair Health formulations
Provider formulation document; versions with and without finasteride
- Hims: Sex Rx + Testosterone Support formula
Provider formulation document; tadalafil and supplement blend, not testosterone replacement
- Hims: Sex Rx + Multivitamin formula
Provider formulation document; tadalafil and listed nutrients
- Hims: Sex Rx + Vitality Pro formula
Provider formulation document; tadalafil and atorvastatin
- Hims: Climax Control and other product formulations
Provider article; tadalafil and fluoxetine identification, not an independent comparison
- BlueChew: named product lineup
Provider article; product identification and marketing claims
- BlueChew: product-specific approximate costs
Provider price examples; approximate and not necessarily consistent with other offer pages
- BlueChew: combination and single-ingredient formulas
Provider article; listed strengths and formulations, not independent comparative evidence
- BlueChew: product access and legacy-plan notice
Provider article; restricts certain products to existing enrolled customers; confirm account eligibility
- BlueChew: VMAX product information
Provider product page; vardenafil and tadalafil strengths
- Rugiet: Daily Boost product information
Provider product page; tadalafil and DHEA combination
- Rugiet: Grower product information
Provider product page; tadalafil and oral minoxidil combination
- MedlinePlus: Vardenafil
Government patient drug information; standard products, not compounded equivalents
- MedlinePlus: Oral minoxidil
Government patient drug information; systemic cardiovascular warnings
- MedlinePlus: Fluoxetine
Government patient drug information; antidepressant warnings and interactions
- MedlinePlus: Atorvastatin
Government patient drug information; statin use, monitoring and adverse effects
- NIH Office of Dietary Supplements: Zinc
Government nutrient information; intake limits and interactions
- Reiter et al. (1999): DHEA and erectile dysfunction
Primary placebo-controlled study, 40 selected men; indexed abstract reviewed
- Morales et al. (2009): androgens and sexual function
Primary randomized study, 86 men; indexed abstract reviewed; no significant sexual-function benefit
- Ro: terms of use, payments and subscriptions
Provider policy; distinguish general subscription terms from Ro Body terms
- Ro Support: canceling an order
Provider support; processing orders and future shipments
- Ro Support: return and refund policy
Provider support; prescription return and refund restrictions
- Ro Support: changing your prescription
Provider support; clinical changes and follow-up
- Hims: Hard Mints formula and safety information
Provider product page; selected formulation and ingredient information
- Hims Support: canceling a subscription
Provider policy; 48-hour notice and orders already processing
- Hims Support: refund policy
Provider policy; no guaranteed refund after pharmacy processing
- Hims Support: when billing occurs
Provider policy; next order date, charge timing, and subscription intervals
- Hims Support: changing the next order date
Provider support; refill rescheduling differs from cancellation
- BlueChew: GOLD published cost breakdown
Provider marketing article; approximate price examples, not a checkout quote
- BlueChew: account and subscription questions
Provider policy; plan changes, one-order skips, and indefinite holds
- BlueChew: shipping and delivery questions
Provider policy; destination availability, shipping, and renewal terms
- BlueChew: returns and refunds policy
Provider policy; prescription returns and 24-hour cancellation notice
- Rugiet: terms and conditions
Provider policy; 72-hour subscription cancellation notice and refund eligibility
- Rugiet Support: canceling an order or subscription
Provider support; member portal steps and processing restrictions
- Rugiet Support: treatment response and refunds
Provider policy; refund exclusions and 24-hour order-change notice
- Rugiet Support: membership options and inclusions
Provider support; plan intervals, shipping, and consultation fees
- EAU: Management of erectile dysfunction
Specialty guideline; clinical evaluation, treatment, and limited combination evidence
- Cui et al. (2015): daily tadalafil with as-needed sildenafil
Primary clinical study; 180 patients, specific regimen, abstract reviewed via NCBI
- Dula et al. (2001): sublingual apomorphine crossover trial
Primary randomized trial; single-ingredient apomorphine, abstract reviewed via NCBI
- Pavone et al. (2004): apomorphine versus sildenafil
Primary crossover study; 34 evaluable participants, abstract reviewed via NCBI
- Behnia et al. (2014): intranasal oxytocin in couples
Primary study; 29 healthy couples, different route and population from GOLD, abstract reviewed via NCBI
- Ro: ED treatment options
Provider source; current treatment catalog
- Ro: medication pricing
Provider source; advertised plan prices and quantities
- Ro: Sparks product details
Provider source; compounded formula, subscription pricing, and care process
- Ro: Daily Rise Gummies
Provider source; compounded tadalafil and billing intervals
- Hims: Hard Mints chewable ED medicines
Provider source; compounded formulations and advertised starting prices
- Hims: generic sildenafil
Provider source; standard tablets and advertised starting price
- BlueChew: platform, care process, and safety information
Provider source; current featured product and service description
- BlueChew: GOLD product and plan information
Provider source; four-ingredient compounded formulation
- Rugiet: Ready product information
Provider source; current compounded product and consultation process
- Rugiet: Ready ingredients explained
Provider source; sildenafil, tadalafil, and apomorphine formulation
- CoreAge Rx: 4Play product information
Provider source; product description and advertised price
- NIDDK: Symptoms & causes of erectile dysfunction
Government patient information
- NIDDK: Diagnosis of erectile dysfunction
Government patient information
- NIDDK: Treatment for erectile dysfunction
Government patient information
- MedlinePlus: Sildenafil
Drug information; standard sildenafil products
- MedlinePlus: Tadalafil
Drug information; standard tadalafil products
- DailyMed: Tadalafil prescribing information, including section 5.11
Prescribing label; not evidence for the 4Play combination
- FDA: Compounding and the FDA — questions and answers
Government guidance on compounded medications
- FDA: Locate a state-licensed online pharmacy
Government pharmacy verification resource
- FDA: Sexual enhancement and energy product notifications
Government safety notifications